For coronary artery bypass grafting (CABG), a ‘no-touch’ technique to harvest the saphenous vein graft has been considered superior to the conventional approach. Surprisingly, a new study comes to a different conclusion.
Nonin Medical, a provider of SpO₂ monitoring solutions, and CO₂ monitoring specialist Corscience have entered into a partnership to co-promote each other’s OEM product offerings.
Using a melt electrowriting (MEW) technique, bioengineers have developed a hybrid structure to address the clinical need for small-diameter vascular grafts and help combat cardiovascular disease.
New resesarch suggests a new way of assessing the risk of heart failure without invasive diagnostic tests. The method involves MRI to measure heart pressure as a predictive factor.
Anxiety and depression hit women harder than men after they have survived cardiac arrest. New research further suggests that age also plays a major role, pointing out the need for more support.
A new 3D graft printing technique offers a potential solution to reduce thrombosis and restrain aneurysmal dilatation post-surgery, with potential for improving cardiovascular disease treatments.
Philips announced its latest AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with AI technology and reduce the burden on echocardiography labs.
A combination of facial thermal imaging and artificial intelligence (AI) can accurately predict the presence of coronary artery disease (CAD), new research finds.
Two companies are combining their unique expertise to develop intelligent e-skin patches to “self-sense” cardiac events in patients. The flexible patch platform will deliver a comprehensive understanding of both electrical and mechanical heart activities and has the potential to enable cardiologists to better monitor their patients.
Researchers were able to produce sub-millimetre resolution images of cardiac micro-vessels. This non-invasive new technique could allow scientists to study the physiology of the heart in more detail.
In cancer, cell deterioration can drive progression. A similar process happens in artherosclerosis, new research reveals. This finding could lead to new ways of combatting disease-causing plaque.
The stiffer the arteries, the greater the cardiovascular risk, according to a new study. The researchers suggest using this as a predictive tool, and emphasise the utility of a specific clinical tool.
AI-enhanced CT scans can accurately evaluate cardiovascular risk without contrast media, a new study shows. The technique uses coronary calcium and heart chamber size as markers for disease detection.
After a stroke or heart attack, the risk of infection is increased – however, why this happens was unknown. Now, researchers found a previously unknown cause – and a therapeutic approach.
Coronary artery disease causes more than 1.8 million heart attacks each year in Europe. In most cases, rehabilitation helps the patients to return to their everyday life. But what happens once the patients have left the rehab clinic?
New approaches to cardiovascular radiology are evolving to help clinicians gain an increasingly better insight into heart conditions. Latest developments in cardiovascular radiology include myocardial strain imaging, 4D flow and photon-counting CT technology. An ECR 2024 session shone the spotlight on these areas of cardiovascular imaging with expert speakers outlining the pros and cons of each.
This February, the Norwegian Institute of Public Health officially launched the ‘Joint Action on cancer and other non-communicable disease prevention project‘ (JA PreventNCD). In the four-year-initiative, 22 EU member states plus Iceland, Norway and Ukraine have joined forces to combat the increasing burden of non-communicable diseases (NCDs) across national borders.
Higher image quality, better spatial resolution: A new radiology study demonstrates how photon-counting CT imaging can improve evaluation of coronary artery disease.
Researchers have developed a 3D-bioprinted, miniaturized chip to advance the understanding of cardiovascular disease and aid in the development of new precision treatments.
